ASR boosts production of thermometer
WESTON, Fla. American Scientific Resources on Thursday announced that due to the reception the company received at the National Association of Chain Drug Stores’ Marketplace Conference held earlier this week in San Diego, ASR has boosted production of its Kidz-Med 5-in-1 non-contact thermometer by an additional 100,000 units to be delivered by the end of the year.
ASR contributed its success at NACDS to the high visibility programs the company was involved in, and to its ability to present an attractive package to the retailers. Additionally, The Greenwood Group, ASR’s sales and marketing team, had a booth located along one of the better-traveled aisles at the conference.
Bayer saluted for blood-glucose meter design
TARRYTOWN, N.Y. Bayer on Wednesday received a silver Medical Design Excellence Award for its Countour USB meter, the company announced. The MDEA recognizes excellence in medical product design and manufacturing.
"Winning a Medical Design Excellence Award is quite an honor," stated Rick Kates, Bayer global senior director, digital health. "We’re gratified that the innovation and hard work that went into bringing this product to life has been so richly recognized.”
With the Countour USB meter, up to 2,000 stored blood glucose measurements can be transferred wirelessly. The blood-glucose measurements are displayed in graph or table form using an integrated diabetes management software that provides diabetes patients and healthcare professionals with access to blood sugar data and trends to help optimize diabetes management.
Lansinoh makes donation to InfantRisk Center
ALEXANDRIA, Va. Lansinoh has made a donation to a center that will provide pregnant and breast-feeding women and their healthcare providers with accurate information and evidence-based counsel on medications that are safe to use and alternatives to drug-based treatments.
The $20,000 donation to InfantRisk Center at Texas Tech University in Amarillo, Texas, will provide mothers and mothers-to-be with information about specific prescription and over-the-counter medications, and will help further drive research on the effects of medications on pregnancies, breast-fed infants and their mothers, and, ultimately, will enhance babies’ health, Lansinoh said.
“It’s great that a resource like this will finally be available in the United States,” said Gina Ciagne, director of breast-feeding and consumer relations at Lansinoh. “The InfantRisk Center is going to be an excellent resource to help clear up any confusion and misinformation regarding medications and whether or not they are safe to use during pregnancy and lactation. Very often, moms are urged to stop breast-feeding because of a perceived conflict with a medication, but that is not always necessary. If the incidence of premature weaning from breast-feeding can be reduced because of information and support that the Center will provide, that will be a great victory.”